Skip to content
Search

Latest Stories

Pharmacist independent prescribers need right support to provide right services, says RPS president

Professor Claire Anderson, president of the Royal Pharmaceutical Society, says pharmacists who have trained as prescribers will need the right support from the NHS to provide patients with the right services.

She wrote in her 'Letter to the Editor' of The Times that despite being qualified, some of them are "unable to provide care that is free to patients because the NHS does not yet fund the service in their area."


The letter was published on the day health secretary Sajid Javid pledged support for utilising all the skills of the pharmacy workforce.

Prof. Anderson wrote: "It is great to see that the health secretary wants to harness the skills of pharmacist prescribers to help to transform patient care and ease pressures on GPs.

"About 20 per cent of pharmacists have already trained as prescribers but frustratingly some are unable to provide care that is free to patients, even though they are qualified, because the NHS does not yet fund the service in their area."

She urged the government to give pharmacists equal access across the country to appropriate information, systems and resources to prescribe safely in all settings.

"Sajid Javid has a huge opportunity to improve access to medicines by providing patients with the right services, and pharmacists with the right support, to facilitate effective NHS prescribing in the community, Anderson said.

"There is everything to gain in terms of easing pressures on the NHS and helping patients to see the right health professional for their needs."

More For You

Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less